Actually bioinvest1, after the R/S, the high was 8.40 before it's long descent down to where we are now. The market just doesn't see a future for ONCS but many of us do and it's taking a long time to develop their technology but hopefully starting in the fall this year, ONCS can prove the market wrong - GLTU